Additional process improvements have been implemented, including refinement of synthesis conditions and impurity control strategies through optimized purification techniques. The Company continues to ...

Analytical performance should lead method decisions, but optimization can still reduce solvent, energy, and waste provided ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance ...

Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...

Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing technologies, is pleased to announce that its ...

The Department of Science and Technology (DOST) has funded an R&D project to develop a rapid and non-destructive diagnostic ...

Designers of essential space and defense systems increasingly look to formal verification to ensure reliability and security ...

Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of ...

The Global Banking & Finance Review Awards programme has officially opened nominations for Best Leadership Development ...

Mindset and economics, not technical feasibility, often block greener solvent adoption; method developers should be ...

Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that the European Patent Office (EPO) has issued a Notice of ...

This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...